Yesterday we held a Tweet Chat with our amazing co-hosts Georgia Hurst and Amy Byer Shainman, and special guest Stephanie Goff, MD, of the National Cancer Institute to discuss what you need to know about immunotherapy and Lynch Syndrome related cancers. We were...
A few short years ago, I had no clue how fast things would change for the Previvor Community when I wrote this post about the need for smarter options to screen for, to treat, and to prevent cancer. Times are changing fast for...
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...